Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Intravenous Steroid in Unilateral Primary Total Knee Replacement
NCT03082092Phase 4Completed
- Sponsor
- Queen Elizabeth Hospital
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone sodium succinate in osteoarthritis (OA), sponsored by Queen Elizabeth Hospital. Started Jun 2017; status: completed.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03082092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03082092.